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Abstract The binding of ligand to B-cell antigen receptors 
(BCR) leads to the activation of receptor-associated Src-family 
kinases and phosphatidylinositol-3’ kinase (PI-3 kinase). 
Although it has been demonstrated that SH3 domains of several 
Src-family kinases interact with PI-3 kinase by binding to a 
proline-rich region of PI-3 kinase in vitro, there is no direct 
evidence to support their interaction in vivo. Thus, we utilized the 
yeast two-hybrid assay to reconstitute this protein-protein 
interaction. This genetic screen clearly indicates that the 
interaction between SH3 domain of Fyn and the proline-rich 
region (residues: 80-104) of PI-3 kinase is highly specific. 
Mutational analysis revealed that amino acid residues Asp9’, 
Tyr93, Arg% and ThrW of the SH3 domain of Fyn are essential 
for interacting with the proline-rich peptide of PI-3 kinase. 
Key words: Fyn; Phosphatidylinositol-3’ kinase; Yeast, two 
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1. Introduction 
Stimulation of B-cell antigen receptor (BCR) initiates sev- 
eral intracellular signaling events that can lead to immune 
proliferation and differentiation [l]. One of the earliest event 
during this signaling pathway is activation of protein tyrosine 
kinases (PTK). Thus far, the BCR-associated PTKs fall into 
two classes: Src-family PTKs (Blk, Lyn and Fyn) and Syk 
kinase [2]. Src-family kinases are rapidly activated following 
BCR crosslinking, and their activation correlates with the in- 
itial tyrosine phosphorylation on the BCR Iga and Igp sub- 
units [3]. Subsequently, this PTK activation results in the tyr- 
osine phosphorylation of several proteins, including 
phosphatidylinositol-3’ kinase (PI-3 kinase), guanosine tri- 
phosphate-activating protein (GAP), protooncogene vav and 
phospholipase C-y2 [4]. 
The PI-3 kinase is a heterodimeric protein composed of a 
non-catalytic ~85 subunit [5] and catalytic ~110 subunits [6]. 
After antigen receptor stimulation, Lyn is associated with the 
p85 subunit of PI-3 kinase [7]. This finding was further sup- 
ported by the in vitro studies, which indicated that SH3 do- 
mains of Src-family kinases such as Lyn and Fyn can stimu- 
late PI-3 kinase activity, presumably by binding to a proline- 
rich region spanning residues W-104 of the ~85 subunit [8]. In 
the present study, we extended this observation by employing 
the yeast two-hybrid assay for a systematic analysis of the 
following: (1) reconstitution of the in vivo protein-protein 
interaction between the SH3 domain of Fyn and the pro- 
line-rich region of PI-3 kinase, and (2) mapping the amino 
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acid residues of the SH3 domain required for interacting 
with the proline-rich region of PI-3 kinase. 
2. Materials and method 
2. I. Yeast strains 
The Saccharomyces cerevisiae strain used was HF7c (MATa ura3- 
52, his3-200, 1~~2-801, ade2-101, trpl-901, leu2-3, 112 gal4-542, galgO- 
538, LYSZ: :GALlUASHIS3, URA3::GAL4-1acZ) as described pre- 
viously [9]. Growth and transformation of yeast cells were performed 
according to standard procedures [lo]. Double transformant yeast 
strains were grown in synthetic drop-out medium to maintain expres- 
sion plasmids. Expression of GAL4 fusion proteins was under the 
control of ADHl piomoter [9]. 
2.2. Construction of yeast expression plasmids 
The wild-type SH3 domain of Fyn (residues: 83-142) or its mutated 
version in which the aspartic acidg2, tyrosineg”, arginineg6 and 
threoninegi were replaced by glycine, serine, tryptophan and isoleu- 
tine respectively via polymerase chain reaction (PCR)-mediated mu- 
tagenesis (Fig. l), were amplified by PCR to contain unique 5’ EcoRI 
and 3’ San restriction sites. An in-frame stop codon was also created 
in front of the SalI site at the 3’ end for both PCR fragments, which 
were inserted into the EcoRI and Safl restriction sites of the yeast 
expression vectors, pGBT9 and pGAD424 [9]. The resulting expres- 
sion plasmids, pGBT9-Fyn (W) and pGBT9-Fyn (M), express GAL4 
DNA-binding domains fused to the wild-type SH3 domain (W) or its 
mutated version (M) of Fyn, whereas pGAD424-Fyn (W) expresses 
GAL4 activation domain fused to the wild-type SH3 domain of Fyn. 
To express in frame fusion proteins of GAL4 DNA-binding or activa- 
tion domains with the proline-rich region of PI-3 kinase, an annealed 
oligonucleotide containing the proline-rich region (residue: 80-104) of 
PI-3 kinase (Fig. 1) was inserted into the EcoRI and Safl restriction 
sites of the yeast expression vectors, pGBT9 or pGAD424. The oli- 
gonucleotide also contains an in-frame stop codon in front of the SalI 
restriction site. The resulting expression plasmids were used to trans- 
form HF7c yeast strain and the double transformant yeast strains 
were selected by leucine and tryptophan auxotrophy. The growth 
phenotype of these double transformant yeast strains was subse- 
quently examined on synthetic drop-out medium in the absence of 
tryptophan, leucine and histidine as described in the two-hybrid assay 
[9,111. 
3. Results and discussion 
The yeast two-hybrid assay has been well documented as a 
powerful genetic screen for investigating protein-protein inter- 
action as well as cloning heterodimeric partners for a protein 
of interest [ll]. In the present study, we further investigated 
the interaction between the SH3 domain of Fyn and the pro- 
line-rich region of PI-3 kinase using this system. In order to 
demonstrate their specific protein-protein interaction, differ- 
ent combinations of GAL4 DNA-binding and activation fu- 
sion constructs were used to transform IIF7c yeast strain and 
the resulting double transformant yeast strains were examined 
for growth phenotype on selective medium. As shown in 
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SH3 Domain of Fyn 
83 142 
Fyn (W): GVTLFVALYPYEA~EDDLSFHKGE~QILNSSEGDWWEGYIPSNYVAPVD 
Fyn (M): . . . . . . . . . . . . . . . . . . . . . . . . . GS . . . . . . WI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ................................... 
80 104 
Proline Rich Region (PI3): KKIS~E~R~REL~VA&!GSSKT 
Fig. 1, Amino acid sequences of the wild-type SH3 domain of Fyn (Fyn (W)), its mutated version (Fyn (M)) and the prolix-rich region of 
phosphatidylinositol 3’ kinase (P13) 
Table 1, all the double transformant yeast strains were able to 
grow on synthetic drop-out medium in the absence of leucine 
and tryptophan (-L-T). However, when these yeast transfor- 
mants were streaked onto selective medium in the absence of 
leucine, tryptophan and histidine (-L-T-H), none of these 
yeast strains could grow except the one, which carries the 
expression plasmids for GAL4 DNA-binding domain fused 
to the wild-type SH3 domain of Fyn and GAL4 activation 
domain fused to the proline-rich region of PI-3 kinase, i.e., 
GBT9-Fyn (W)+GAD424-P13. The specificity of this protein- 
protein interaction is further supported by the notion that this 
growth phenotype was not observed when the wild-type SH3 
domain of Fyn was substituted by its mutated version, i.e., 
GBT9-Fyn (M)+GAD424-P13. The other direct evidence 
which supports this specific protein-protein interaction is 
the presence of yeast transformants selected from the medium 
lacking histidine. As shown in Fig. 2, when HF7c yeast strain 
was cotransformed with the plasmids, GBT9-Fyn 
(M)+GAD424-PI3 (left) or GBT9-Fyn (W)+GAD424-PI3 
(right) and plated onto selective medium (-L-T-H), transfor- 
mants appeared on selective medium only when the GAL4 
binding domain was fused with the wild-type SH3 domain 
(right) but not with the mutant SH3 domain (left). These yeast 
transformants were also shown to exhibit p-gal activity. Thus, 
this observation clearly indicates that the SH3 domain (resi- 
dues: 83-142) of Fyn can interact specifically with the proline- 
rich region (residues: 80-104) of PI-3 kinase in vivo further 
supporting their interaction in vitro [8]. It is also interesting to 
note that the other combination of the wild-type SH3 domain 
and proline-rich region of PI-3 kinase with the yeast two 
hybrid expression vectors, i.e., GBT9-PI3+GAD424-Fyn (W) 
did not give rise to the expected growth phenotype, indicating 
that proper folding of GAL4 fusion proteins is required to 
reconstitute GAL4 function in the yeast two-hybrid assay. 
Mutational analysis of the SH3 domain revealed that four 
amino acids namely Aspg2, Tyrg3, Argg6 and Thrg7 are essen- 
Fig. 2. Growth selection of yeast transformants on selective medium lacking tryptophan, leucine and histidine. The yeast strain, HF7c was co- 
transformed with the plasmids pGBT9-fyn (M)+pGAD424-PI3 (left plate) or pGBT9-fyn (W)+pGAD424-PI3 (right plate) according to stand- 
ard protocol as described in Section 2. Double yeast transformants were selected on medium lacking leucine, tryptophan and histidine (-L-T-H) 
after 5 days incubation at 30°C. pGBT9-fyn (M) and pGBT9-fyn (W) represent GAL4 DNA-binding domain fused to the mutated or wild- 
type SH3 domain of fyn, respectively, whereas pGAD424-PI3 represents GAL4 activation domain fused to the proline rich region of PI-3 ki- 
nase. 
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Table 1 
Summary of growth phenotype exhibited by different yeast strains 
in the yeast two-hybrid assay 
Yeast strains -L-T -L-T-H 
GBT9+GAD424 + - 
GBT9-Fyn (W)+GAD424 + _ 
GBT9-Fyn (M)+GAD424 + _ 
GBT9+GAD424-PI3 + _ 
GBT9-Fyn (M)+GAD424-PI3 + _ 
GBT9-Fyn (W)+GAD424-PI3 + + 
GBT9-PI3+GAD424-Fyn (W) + _ 
The yeast strain (HF7c) was transformed with the two empty expres- 
sion plasmids (GBT9 and GAD424 ) or with the fusion plasmids as 
indicated. GBT9-Fyn (W), GBT9-Fyn (M) and GBT9-PI3 are the 
plasmids, which express GAL4 DNA-binding domains fused to the 
wild-type (W), the mutated (M) version of Fyn-SH3 domain or the 
proline-rich region of phosphatidylinositol-3’ kinase (PI-3), respec- 
tively. GAD424-Fyn (W) and GAD424-PI3 are the plasmids, which 
express GAL4 activation domains fused to the wild-type (w) of Fyn- 
SH3 domain or the proline-rich region of PI-3 kinase, respectively. 
Double transformant yeast strains were selected by leucine and tryp- 
tophan auxotrophy (-L-T). Growth phenotype of these double trans- 
formant yeast cells was examined on selective medium in the absence 
of leucine, tryptophan and histidine (-L-T-H) after 34 days incuba- 
tion at 30°C. 
tial for interacting with the proline-rich peptide of PI-3 kinase. 
These data are in good agreement with the previous analysis 
from the crystallography of SH3 domains [12]. 
Although the exact role of PI-3 kinase in BCR signal trans- 
duction has not been determined, several lines of evidence 
suggest that activation of this eniyme is essential for cell pro- 
liferation upon growth factor receptor stimulation such as the 
platelet-derived growth factor receptor (PDGF) [13]. Thus, it 
is very likely that PI-3 kinase activation pathway is critical for 
BCR-induced cell proliferation. Taken together, the yeast 
two-hybrid system has faithfully reproduced the in vitro inter- 
action between SH3 domain of Fyn and the proline-rich pep- 
tide of PI-3 kinase [8]. The functional reconstitution of this 
specific protein-protein interaction in yeast can now be 
exploited as a screening assay to identify specific blockers 
(chemicals) for BCR-induced PI-3 kinase activation. Assum- 
ing the importance of PI-3 kinase in BCR signaling, these 
chemicals have great potential for intervention for B-cell acti- 
vation. Concurrently, further mutational analysis of the four 
amino acids required for this protein-protein interaction 
might provide key information in rational drug design for 
immunomodulatory agents. 
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